fig1
![The dark side of immunotherapy: pancreatic cancer](https://image.oaes.cc/dfbe201a-ce2c-4367-b19e-5c368e0e244a/3441.fig.1.jpg)
Figure 1. Immunotherapy intervention in the different steps of antitumor response. In this review, we will describe the current landscape of preclinical and clinical advances made in immunotherapy applied to pancreatic cancer. APC: antigen-presenting cell; CAR: chimeric antigen receptor